Ayurveda tech startup NirogStreet raises Rs 100 crore approximately

Published On 2022-11-20 05:30 GMT   |   Update On 2022-11-20 05:30 GMT

New Delhi: Ayurveda tech startup NirogStreet on Friday said it has raised USD 12 million (nearly Rs 100 crore) in a round led by Jungle Ventures.The family office of investor Anthony Weldon has also come onboard as a new investor, while existing investors Spiral Ventures, ICMG Co-Creation Fund, DoorDash's Gokul Rajaram, SMBC APAC co-head Rajeev Kannan also participated in Series B funding...

Login or Register to read the full article

New Delhi: Ayurveda tech startup NirogStreet on Friday said it has raised USD 12 million (nearly Rs 100 crore) in a round led by Jungle Ventures.

The family office of investor Anthony Weldon has also come onboard as a new investor, while existing investors Spiral Ventures, ICMG Co-Creation Fund, DoorDash's Gokul Rajaram, SMBC APAC co-head Rajeev Kannan also participated in Series B funding round, the company said in a statement.

''This new fundraise will help us strengthen our supply chain, service offerings, and tech that will help us realise the vision we are working to achieve,'' NirogStreet Founder and CEO Ram N Kumar said.

The company is streamlining the supply chain of Ayurvedic services and medicines ''to enable the doctors to deliver trusted healthcare and working towards making Ayurveda the first call of treatment'', he added.

NirogStreet claims to have over 50,000 Ayurvedic doctors in its community.

It has also created a knowledge-sharing platform for the practitioners and a verified marketplace of Ayurvedic medicines from where doctors can directly order and fill prescriptions while staying on the platform, the company said.

Read also: Saveo Healthtech raises over Rs 36 crore in funding round

Founded in 2016, NirogStreet is a Ayurveda tech startup.

Tags:    
Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News